R&D
![darts](https://pharmaphorum.com/wp-content/uploads/2023/01/darts-g96682ed11_840.jpg)
Taking an ‘upside-down’ approach to mRNA delivery
Ben Hargreaves speaks to Liberate Bio, a company that is hoping to address the delivery issues that could prevent mRNA, as well as siRNA and ASO therapeutics, from reaching their full poten